Drugs Information: Avanafil
Basic Information
|
||
| ID | DDInter141 | |
| Drug Type | small molecule | |
| Molecular Formula | C23H26Cln7O3 | |
| Molecular Weight | 483.960 | |
| Description | Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used to treat erectile dysfunction. | |
| ATC Classification | G04BE10 | |
| IUPAC Name | 4-{[(3-Chloro-4-Methoxyphenyl)Methyl]Amino}-2-[(2S)-2-(Hydroxymethyl)Pyrrolidin-1-Yl]-N-(Pyrimidin-2-Ylmethyl)Pyrimidine-5-Carbo | |
| InChI | Inchi=1S/C23H26Cln7O3/C1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/H3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/T16-/M0/S1 | |
| InChI Key | WEAJZXNPAWBCOA-INIZCTEOSA-N | |
| Canonical SMILES | COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1 | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Avanafil
| Severity level | ID | Name | Mechanism | Detail |
|---|